AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Ss&c Technologies: DA Davidson maintains a 'Buy' Rating, The Target Price is $102
ByAinvest
Friday, Jul 25, 2025 4:00 pm ET1min read
DA Davidson maintains 'Buy' rating on Ss&c Technologies(SSNC).
The target price is $102, compare with $98 previously.
[Recent Rating]
| Date | Agency | Change | Rating | Rating （previously） | Target Price | Target Price（previously） |
|---|---|---|---|---|---|---|
| 2025-07-25 | DA Davidson | Maintains | Buy | Buy | $102 | $98 |
| 2025-07-24 | UBS | Maintains | Buy | Buy | $108 | $105 |
| 2025-07-24 | Needham | Maintains | Buy | Buy | $100 | $90 |
| 2025-07-24 | Raymond James | Maintains | Strong Buy | Strong Buy | $95 | $90 |
| 2025-07-24 | JP Morgan | Maintains | Neutral | Neutral | $94 | $86 |
| 2025-07-14 | DA Davidson | Maintains | Buy | Buy | $98 | $94 |
[Recent Earning Results] Ss&C Technologies posted the Q2 of its 2025 financial results on 7/23/2025, reporting total revenue of USD 3050.70 million in the first half of the year, up 5.69% from USD 2886.50 million year over year, reporting net income of USD 394.30 million in the first half of the year, up 13.08% from USD 348.70 million year over year.
[Company Profile] Ss&C Technologies Holdings, Inc. incorporated in Delaware as Sunshine Acquisition Corporation in July 2005, is a leading provider of mission-critical, sophisticated software products and software-enabled services that allow financial services providers to automate complex business processes and effectively manage their information processing requirements.The company is a leading provider of mission-critical, sophisticated software products and software-enabled services that allow financial services providers to automate complex business processes and effectively manage their information processing requirements. The company's provide solutions globally to thousands of clients, principally within the institutional asset and wealth management, alternative investment management, brokerage, retirement, financial advisory and financial institutions vertical markets. In addition, The company's provide solutions to the healthcare industry including pharmacy, healthcare administration and health outcomes optimization solutions to satisfy their information processing, quality of care, cost management and payment integrity needs. The company's healthcare solutions include claims adjudication, benefit management, care management and business intelligence services.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet